Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors.
Saved in:
| Title: | Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors. |
|---|---|
| Authors: | Ortendahl JD; Stratevi, Boston, MA, USA., Carter GC; Exact Sciences Corporation, Madison, WI, USA., Zantema EM; Stratevi, Boston, MA, USA., Hoag JR; Exact Sciences Corporation, Madison, WI, USA., Starodynov A; Exact Sciences Corporation, Madison, WI, USA., White KL; Exact Sciences Corporation, Madison, WI, USA., Basu GD; Exact Sciences Corporation, Madison, WI, USA., Tharayanil A; Exact Sciences Corporation, Madison, WI, USA., De La O JP; Exact Sciences Corporation, Madison, WI, USA., Hall DW; Exact Sciences Corporation, Madison, WI, USA., Baehner FL; Exact Sciences Corporation, Madison, WI, USA. |
| Source: | Journal of medical economics [J Med Econ] 2026 Dec; Vol. 29 (1), pp. 1046-1058. Date of Electronic Publication: 2026 Mar 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
